Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Type 1 Diabetes Preclinical Testing Program Resource Report Resource Website |
Type 1 Diabetes Preclinical Testing Program (RRID:SCR_006861) | T1D-PTP, NIDDKT1D-PTP | service resource, resource | THIS RESOURCE IS NO LONGER IN SERVICE, documented August 22, 2016. Investigator access is provided to the established facilities and expertise needed to extend, enhance and validate preclinical studies of promising new therapeutics in cases where additional preclinical testing is needed to validate potential therapies under disease-specific conditions and in multiple animal models before therapeutics can enter the Type 1 Diabetes Rapid Access to Intervention Development (T1D-RAID) development pipeline. The T1D-RAID program provides resources for pre-clinical development of drugs, natural products, and biologics that will be tested as new therapeutics in type 1 diabetes clinical trials. The T1D-RAID program is not currently accepting applications. The T1D-PTP program currently supports two contracts, which are separate from each other and from the T1D-RAID NCI contract resources, to assist in preclinical development of therapeutics for T1D: * Agents to be tested for Preclinical Efficacy in Prevention or Reversal of Type 1 Diabetes in Rodent Models. Type 1 Diabetes Preclinical Testing Program (T1D-PTP) (NOT-DK-09-006) * Needs for Preclinical Efficacy Testing of Promising Agents to Prevent or Reverse Diabetic Complications (NOT-DK-09-009) The T1D-RAID and T1D-PTP are programs intended to remove the most common barriers to progress in identification and development of new therapies for Type 1 Diabetes. The common goal of these programs is to support and provide for the preclinical work necessary to obtain proof of principle establishing that a new molecule or novel approach will be a viable candidate for expanded clinical evaluation. | testing, therapeutic, clinical, drug, preclinical, therapy, drug development, high-throughput screening, animal model, formulation, pharmacology, toxicology |
is related to: Type 1 Diabetes - Rapid Access to Intervention Development is related to: NIDDK Information Network (dkNET) has parent organization: NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases |
Type 1 diabetes, Diabetes | NIDDK | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_152741 | SCR_006861 | Type 1 Diabetes Preclinical Testing Program (T1D-PtP), NIDDKType 1 Diabetes Preclinical Testing Program | 2026-08-13 09:27:38 | 0 | |||||
|
Type 1 Diabetes - Rapid Access to Intervention Development Resource Report Resource Website |
Type 1 Diabetes - Rapid Access to Intervention Development (RRID:SCR_000203) | T1D-RAID | service resource, resource | NOTE: The T1D-RAID program is not currently accepting applications. Cooperative program that makes available, on a competitive basis, NCI resources for the pre-clinical development of drugs, natural products, and biologics to facilitate translation to the clinic of novel, scientifically meritorious therapeutic interventions for type 1 diabetes and its complications. A partial listing of those services includes: high-throughput screening, studies in animal models, formulation, pharmacology and toxicology studies, and bulk substances acquisition. Requests to T1D-RAID are brief (20 pages or less), and should clearly outline the resources required to ready the proposed therapeutic agent for clinical trials. T1D-RAID should enable entry into the clinic of promising molecules that are not otherwise likely to receive an adequate and timely clinical test. T1D-RAID is designed to accomplish the tasks that are rate-limiting in bringing discoveries from the laboratory to the clinic. Once a project has been approved, NIDDKstaff interact directly with the Principal Investigator (PI). NCI contractors perform the T1D-RAID-approved tasks under the direction of NIDDKand NCI staff. The required tasks will vary from project to project. In some cases T1D-RAID will support only one or two key missing steps necessary to bring a compound to the clinic; in other cases it may be necessary to supply the entire portfolio of development requirements needed to file an IND. Examples of tasks that can be supported by T1D-RAID include, but are not limited to: * Definition or optimization of dose and schedule for in vivo activity * Development of pharmacology assays * Conduct of pharmacology studies with a pre-determined assay * Acquisition of bulk substance (GMP and non-GMP) * Scale-up production from lab-scale to clinical-trials lot scale * Development of suitable formulations * Development of analytical methods for bulk substances * Production of dosage forms * Stability assurance of dosage forms * Range-finding initial toxicology * IND-directed toxicology, with correlative pharmacology and histopathology * Planning of clinical trials * Regulatory affairs, so that FDA requirements are likely to be satisfied by participating investigators seeking to test new molecular entities in the clinic * IND filing advice The output of T1D-RAID activities will be both products and information that will be made fully available to the originating investigator for support of an IND application and clinical trials. T1D-RAID does not sponsor clinical trials. | therapeutic, drug, drug development, pharmacogenomics |
is listed by: NIDDK Information Network (dkNET) is related to: Type 1 Diabetes Preclinical Testing Program has parent organization: NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases |
Type 1 diabetes, Diabetes | NCI ; NIDDK |
nlx_152742 | SCR_000203 | Type 1 Diabetes - Rapid Access to Intervention Development (T1D-RAID) | 2026-08-13 09:26:08 | 0 | ||||||
|
National Diabetes Education Program Resource Report Resource Website 10+ mentions |
National Diabetes Education Program (RRID:SCR_001477) | NDEP | training resource, resource | Federal government public education program that promotes diabetes prevention and control. They aim to reduce the morbidity and mortality associated with diabetes and its complications. The NDEP is jointly sponsored by the National Institutes of Health and the Centers for Disease Control and Prevention and over 200 partner organizations. Target audiences include people with diabetes and those at risk, including the racial and ethnic populations disproportionately affected by the disease, health care providers and payers and purchasers of health care. | treatment, outcome, diabetes, diagnosis, prevention, blood glucose level, complication, education, disease-related portal |
is listed by: NIDDK Information Network (dkNET) has parent organization: NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases |
Type 1 diabetes, Type 2 diabetes, Diabetes | NIDDK N02DK72927-8-0-1 | Free, Freely available | nlx_152708 | SCR_001477 | 2026-08-13 09:26:22 | 38 | ||||||
|
Diabetes Research Centers Resource Report Resource Website 1+ mentions |
Diabetes Research Centers (RRID:SCR_014535) | topical portal, data or information resource, organization portal, disease-related portal, resource, portal | Diabetes Research Centers (DRC) is an integrated program of diabetes, endocrinology and metabolism research. | diabetes research, endocrinology research, metabolism research |
lists: Preventing Early Renal Loss in Diabetes (PERL) lists: Clinical Trials in Organ Transplantation (CTOT) lists: Stanford Diabetes Research Center lists: Clinical Islet Transplantation Consortium (CITC) lists: Restoring Insulin Secretion Consortium (RISE) lists: Digestive Disease Centers lists: Drug-Induced Liver Injury Network lists: Nutrition and Obesity Research Centers lists: Chronic Renal Insufficiency Cohort Study lists: Glycemic Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) lists: Diabetes Prevention Type 1 lists: Monogenic Diabetes Registry lists: Chronic Prostatitis Collaborative Research Network Clinical Trial- Alfuzosin lists: National Glycohemoglobin Standardization Program is listed by: NIDDK Information Network (dkNET) is affiliated with: University of California at San Diego; California; USA is affiliated with: University of California at Los Angeles; California; USA is affiliated with: University of California at San Francisco; California; USA is affiliated with: Columbia University; New York; USA is affiliated with: Albert Einstein College of Medicine; New York; USA is affiliated with: Indiana University; Indiana; USA is affiliated with: Johns Hopkins University; Maryland; USA is affiliated with: University of Maryland; Maryland; USA is affiliated with: Joslin Diabetes Center is affiliated with: University of Alabama at Birmingham; Alabama; USA is affiliated with: University of Michigan; Ann Arbor; USA is affiliated with: University of Pennsylvania; Philadelphia; USA is affiliated with: University of Washington; Seattle; USA is affiliated with: Vanderbilt University; Tennessee; USA is affiliated with: Washington University in St. Louis; Missouri; USA is affiliated with: Yale University; Connecticut; USA is affiliated with: Yale Diabetes Research Center is affiliated with: University of Washington Diabetes Research Center is affiliated with: Penn Diabetes Research Center is affiliated with: University of Chicago Diabetes Research and Training Center is affiliated with: University of Alabama at Birmingham Diabetes Research Center is affiliated with: University of California San Francisco Diabetes Research Center is affiliated with: University of California San Diego - University of California Los Angeles Diabetes Research Center is affiliated with: Indiana Diabetes Research Center is affiliated with: Columbia Diabetes Research Center is affiliated with: Einstein-Mount Sinai Diabetes Research Center is affiliated with: NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases has organization facet: Joslin Diabetes Center has organization facet: Yale Diabetes Research Center has organization facet: University of Washington Diabetes Research Center has organization facet: Penn Diabetes Research Center has organization facet: University of Chicago Diabetes Research and Training Center has organization facet: Michigan Diabetes Research Center has organization facet: University of Alabama at Birmingham Diabetes Research Center has organization facet: University of California San Francisco Diabetes Research Center has organization facet: University of California San Diego - University of California Los Angeles Diabetes Research Center has organization facet: Indiana Diabetes Research Center has organization facet: Columbia Diabetes Research Center has organization facet: Einstein-Mount Sinai Diabetes Research Center has organization facet: Stanford Diabetes Research Center has organization facet: Boston Area Diabetes Endocrinology Research Center has organization facet: Johns Hopkins University - University of Maryland Diabetes Research Center has organization facet: Vanderbilt Diabetes Research and Training Center has organization facet: Washington University School of Medicine Diabetes Research Center has organization facet: Center for American Indian and Alaska Native Diabetes Translational Research |
Type 1 diabetes, Type 2 diabetes, Diabetes | Available to the research community | SCR_014535 | 2026-08-13 09:29:03 | 1 | |||||||||
|
Accelerating Medicines Partnership Type 2 Diabetes Knowledge Portal (AMP-T2D) Resource Report Resource Website 50+ mentions |
Accelerating Medicines Partnership Type 2 Diabetes Knowledge Portal (AMP-T2D) (RRID:SCR_003743) | AMP T2D, T2DKP | topical portal, data or information resource, disease-related portal, database, service resource, data repository, storage service resource, portal | Portal and database of DNA sequence, functional and epigenomic information, and clinical data from studies on type 2 diabetes and analytic tools to analyze these data. .Provides data and tools to promote understanding and treatment of type 2 diabetes and its complications. Used for identifying genetic biomarkers correlated to Type 2 diabetes and development of novel drugs for this disease. | type 2 diabetes, diabetes, knowledge, portal, database, repository, type II, diabetic, genetic, data, analysis, FASEB list |
is recommended by: NIDDK Information Network (dkNET) is recommended by: National Library of Medicine is recommended by: NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases is listed by: Consortia-pedia is listed by: NIDDK Information Network (dkNET) is related to: Accelerating Medicines Partnership - Alzheimers is related to: Accelerating Medicines Partnership - Alzheimers is related to: Accelerating Medicines Partnership Autoimmune Diseases of Rheumatoid Arthritis and Lupus is related to: Type 1 Diabetes Knowledge Portal is related to: Common Metabolic Diseases Knowledge Portal has parent organization: Foundation for the National Institutes of Health has parent organization: Accelerating Medicines Partnership |
Type 2 diabetes, Diabetes | NIH ; University of Michigan ; Broad Institute ; Fundacion Carlos Slim ; NIDDK |
Free, Freely available | SCR_014533, nlx_157976 | http://www.nih.gov/science/amp/type2diabetes.htm | SCR_003743 | , AMP Diabetes, AMP, T2D, AMP-T2D, Type 2 Diabetes Knowledge Portal, Accelerating Medicines Partnership Type 2 Diabetes, Accelerating Medicines Partnership Type 2 Diabetes Knowledge Portal, The AMP-T2D Knowledge Portal, AMP T2D, AMP Type 2 Diabetes | 2026-08-13 09:27:00 | 83 | ||||
|
Juvenile Diabetes Research Foundation Resource Report Resource Website 50+ mentions |
Juvenile Diabetes Research Foundation (RRID:SCR_001522) | JDRF | institution | Global funder of type 1 diabetes (T1D) research that aims to progressively remove the impact of T1D from people's lives until a world without T1D is achieved. JDRF collaborates with a wide spectrum of partners and is the only organization with the scientific resources, regulatory influence, and a working plan to better treat, prevent, and eventually cure T1D. More than 80 percent of JDRF's expenditures directly support research and research-related education. In 2012 Forbes magazine named JDRF one of its five All-Star charities, citing the organization's efficiency and effectiveness. The organization awards research grants for laboratory and clinical investigations and sponsors a variety of career development and research training programs for new and established investigators. JDRF also sponsors international workshops and conferences for biomedical researchers. Individual chapters offer support groups and other activities for families affected by diabetes. | treatment, prevention, cure, research, education |
is listed by: NIDDK Information Network (dkNET) is affiliated with: Helmsley Cellular Research Hub is related to: JDRF Artificial Pancreas Project Consortium is related to: Kidney Health Initiative |
Type 1 diaberes, Diabetes | Free, Freely available | grid.429307.b, nlx_152841, Crossref funder ID: 100008871, Wikidata: Q6107958, ISNI: 0000 0004 0575 6413 | https://ror.org/00vqxjy61 | SCR_001522 | JDRF International, Juvenile Diabetes Research Foundation International | 2026-08-08 11:57:28 | 66 | |||||
|
Medtronic Resource Report Resource Website 1000+ mentions |
Medtronic (RRID:SCR_003988) | MDT | commercial organization | Medical technology company that develops and manufactures devices and therapies to treat more than 30 chronic diseases, including heart failure, Parkinson's disease, urinary incontinence, Down syndrome, obesity, chronic pain, spinal disorders, and diabetes. A Commercial healthcare organization for both patients and healthcare professionals. For professionals, it provides products, therapy and procedure solutions, and services. | medical device, cardiac, vascular, restorative therapy, neuromodulation, spine, heart, aorta, coronary, surgical technology | is related to: Kidney Health Initiative | Cardiac disease, Vascular disease, Diabetes, Neurological condition, Musculoskeletal condition, Heart failure, Parkinson's disease, Urinary incontinence, Down's syndrome, Obesity, Chronic pain, Spinal disorder | grid.481699.b, nlx_158399, Wikidata: Q30343856, SCR_010517, nlx_17750, grid.487289.8 | https://ror.org/04fhmmg24, https://ror.org/01y0zfy93 | SCR_003988 | Medtronic Inc. | 2026-08-13 09:26:57 | 2841 | ||||||
|
Centers for Diabetes Translation Research Resource Report Resource Website 1+ mentions |
Centers for Diabetes Translation Research (RRID:SCR_015149) | topical portal, data or information resource, organization portal, disease-related portal, resource, portal | Centers that are part of an integrated program whose cores support and enhance diabetes type II translation research. The CDTRs aim to enhance the efficiency, productivity, effectiveness and multidisciplinary nature of diabetes translation research. | diabetes type ii, diabetes research, translation |
is listed by: NIDDK Information Network (dkNET) is affiliated with: Vanderbilt Center for Diabetes Translation Research is affiliated with: New York Regional Center for Diabetes Translation Research is affiliated with: Chicago Center for Diabetes Translation Research is affiliated with: Georgia Center for Diabetes Translation Research is affiliated with: Michigan Center for Diabetes Translational Research is affiliated with: NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases has organization facet: Chicago Center for Diabetes Translation Research has organization facet: New York Regional Center for Diabetes Translation Research has organization facet: Georgia Center for Diabetes Translation Research has organization facet: Health Delivery Systems Center for Diabetes Translational Research has organization facet: Michigan Center for Diabetes Translational Research has organization facet: Vanderbilt Center for Diabetes Translation Research has organization facet: Washington University Center for Diabetes Translation Research |
Diabetes | NIDDK P30RFA-DK15-003 | Available to the research community | SCR_015149 | 2026-08-13 09:29:08 | 1 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the dkNET Resources search. From here you can search through a compilation of resources used by dkNET and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that dkNET has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on dkNET then you can log in from here to get additional features in dkNET such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into dkNET you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
The NIDDK Information Network (dkNET) serves the needs of basic and clinical investigators by providing seamless access to large pools of data and research resources relevant to the mission of The National Institute of Diabetes Digestive and Kidney Diseases (NIDDK). dkNET is hosted at University of California San Diego, and is supported by NIH NIDDK grant U24DK097771.
Email: info_at_ dknet.org
